NEDD4L and atherosclerosis: NEDD4L-targeted therapies could enhance the anti-inflammatory potential of these drugs, therefore reducing pro-inflammatory cytokines more effectively and preventing macrophage polarization to the inflammatory pathway, leading to better atherosclerosis treatment results.